Afya (NASDAQ:AFYA – Get Free Report) had its target price increased by stock analysts at UBS Group from $17.50 to $19.50 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. UBS Group’s price objective indicates a potential upside of 7.68% from the company’s previous close.
Several other equities analysts have also issued reports on AFYA. Wall Street Zen lowered Afya from a “buy” rating to a “hold” rating in a research report on Friday, June 6th. Morgan Stanley cut shares of Afya from an “equal weight” rating to an “underweight” rating and reduced their price target for the company from $19.00 to $17.00 in a report on Tuesday, March 11th. Three equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $17.60.
Check Out Our Latest Analysis on Afya
Afya Stock Performance
Hedge Funds Weigh In On Afya
Hedge funds have recently made changes to their positions in the business. BNP Paribas Financial Markets bought a new position in Afya in the fourth quarter valued at $228,000. Wellington Management Group LLP bought a new position in shares of Afya in the 4th quarter valued at about $829,000. Two Sigma Advisers LP increased its position in shares of Afya by 27.2% in the fourth quarter. Two Sigma Advisers LP now owns 78,600 shares of the company’s stock valued at $1,248,000 after acquiring an additional 16,800 shares during the last quarter. Teacher Retirement System of Texas acquired a new stake in shares of Afya in the fourth quarter valued at about $329,000. Finally, Northern Trust Corp raised its holdings in Afya by 109.7% during the fourth quarter. Northern Trust Corp now owns 40,054 shares of the company’s stock worth $636,000 after acquiring an additional 20,957 shares in the last quarter. 88.02% of the stock is owned by institutional investors.
About Afya
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Recommended Stories
- Five stocks we like better than Afya
- What is the Nasdaq? Complete Overview with History
- IBM Up 10 Days in a Row: What’s Driving the Winning Streak?
- Dividend Payout Ratio Calculator
- Upstart Stock’s Bull Case Just Got a Lot Stronger
- What to Know About Investing in Penny Stocks
- Higher Gulf Oil Output Puts These Energy Names in Play
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.